SCHWARTZ MARK W. 4
4 · Galena Biopharma, Inc. · Filed Sep 26, 2011
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2011-09-07+250,000→ 250,000 totalExercise: $1.00Exp: 2021-09-07→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Granted pursuant to the issuer's 2007 Incentive Plan
- [F2]Option vested and became exercisable immediately on the date of grant (i.e., September 7, 2011)